OTCPK:IUSD.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. More Details

Rewards

Earnings are forecast to grow 10.12% per year

Earnings have grown 9.5% per year over the past 5 years

Risk Analysis

No risks detected for IUSD.F from our risk checks.


Snowflake Analysis

Excellent balance sheet with proven track record.

Share Price & News

How has AS ONE's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IUSD.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

IUSD.F

3.4%

US Healthcare

2.3%

US Market


1 Year Return

n/a

IUSD.F

22.3%

US Healthcare

17.2%

US Market

Return vs Industry: Insufficient data to determine how IUSD.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how IUSD.F performed against the US Market.


Shareholder returns

IUSD.FIndustryMarket
7 Day0%3.4%2.3%
30 Day0%-3.8%-4.6%
90 Dayn/a-1.3%7.4%
1 Yearn/a23.9%22.3%19.8%17.2%
3 Yearn/a23.3%17.9%37.4%28.3%
5 Yearn/a52.4%41.5%83.8%63.0%

Price Volatility Vs. Market

How volatile is AS ONE's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is AS ONE undervalued compared to its fair value and its price relative to the market?

47.21x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: IUSD.F ($109) is trading above our estimate of fair value ($52.35)

Significantly Below Fair Value: IUSD.F is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IUSD.F is poor value based on its PE Ratio (47.2x) compared to the US Healthcare industry average (21.1x).

PE vs Market: IUSD.F is poor value based on its PE Ratio (47.2x) compared to the US market (17.5x).


Price to Earnings Growth Ratio

PEG Ratio: IUSD.F is poor value based on its PEG Ratio (4.7x)


Price to Book Ratio

PB vs Industry: IUSD.F is overvalued based on its PB Ratio (4.9x) compared to the US Healthcare industry average (2.7x).


Next Steps

Future Growth

How is AS ONE forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

10.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IUSD.F's forecast earnings growth (10.1% per year) is above the savings rate (2.2%).

Earnings vs Market: IUSD.F's earnings (10.1% per year) are forecast to grow slower than the US market (22.9% per year).

High Growth Earnings: IUSD.F's earnings are forecast to grow, but not significantly.

Revenue vs Market: IUSD.F's revenue (7.3% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: IUSD.F's revenue (7.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IUSD.F's Return on Equity is forecast to be low in 3 years time (12%).


Next Steps

Past Performance

How has AS ONE performed over the past 5 years?

9.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IUSD.F has high quality earnings.

Growing Profit Margin: IUSD.F's current net profit margins (8.3%) are higher than last year (7.9%).


Past Earnings Growth Analysis

Earnings Trend: IUSD.F's earnings have grown by 9.5% per year over the past 5 years.

Accelerating Growth: IUSD.F's earnings growth over the past year (12.7%) exceeds its 5-year average (9.5% per year).

Earnings vs Industry: IUSD.F earnings growth over the past year (12.7%) underperformed the Healthcare industry 31.1%.


Return on Equity

High ROE: IUSD.F's Return on Equity (10.4%) is considered low.


Next Steps

Financial Health

How is AS ONE's financial position?


Financial Position Analysis

Short Term Liabilities: IUSD.F's short term assets (¥47.7B) exceed its short term liabilities (¥19.2B).

Long Term Liabilities: IUSD.F's short term assets (¥47.7B) exceed its long term liabilities (¥6.6B).


Debt to Equity History and Analysis

Debt Level: IUSD.F's debt to equity ratio (11.4%) is considered satisfactory.

Reducing Debt: IUSD.F's debt to equity ratio has increased from 11.1% to 11.4% over the past 5 years.

Debt Coverage: IUSD.F's debt is well covered by operating cash flow (97.1%).

Interest Coverage: IUSD.F earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is AS ONE current dividend yield, its reliability and sustainability?

0.80%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: IUSD.F's dividend (0.81%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.75%).

High Dividend: IUSD.F's dividend (0.81%) is low compared to the top 25% of dividend payers in the US market (4.99%).


Stability and Growth of Payments

Stable Dividend: IUSD.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: IUSD.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: IUSD.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IUSD.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.4yrs

Average management tenure


CEO

Takuji Iuchi (52 yo)

11.25yrs

Tenure

JP¥107,000,000

Compensation

Mr. Takuji Iuchi has been the President of As One Corp. since June 2009. Mr. Iuchi has been the President of As One (Shanghai) Corporationsince April 2007. Mr. Iuchi served as General Manager of Marketing ...


CEO Compensation Analysis

Compensation vs Market: Takuji's total compensation ($USD0.00) is below average for companies of similar size in the US market ($USD5.74M).

Compensation vs Earnings: Insufficient data to compare Takuji's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Takuji Iuchi
President & Representative Director11.25yrsJP¥107.00m0.38%
¥ 10.1m
Kazuhito Yamada
MD, GM of Marketing Division & Sales Division8.25yrsno data0.14%
¥ 3.7m
Mototaka Ono
MD, GM of Corporate Planning Division & Director11.25yrsno data0.017%
¥ 440.7k
Yasuyuki Hoshino
GM of International Business Division & International Department and Director8.25yrsno data0.033%
¥ 867.4k
Kenichi Fujinaka
GM of Merchandising Division & IT Division and Directorno datano data0.11%
¥ 3.0m

11.4yrs

Average Tenure

59yo

Average Age

Experienced Management: IUSD.F's management team is seasoned and experienced (11.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Takuji Iuchi
President & Representative Director11.25yrsJP¥107.00m0.38%
¥ 10.1m
Kazuhito Yamada
MD, GM of Marketing Division & Sales Division8.25yrsno data0.14%
¥ 3.7m
Mototaka Ono
MD, GM of Corporate Planning Division & Director11.25yrsno data0.017%
¥ 440.7k
Yasuyuki Hoshino
GM of International Business Division & International Department and Director8.25yrsno data0.033%
¥ 867.4k
Kenichi Fujinaka
GM of Merchandising Division & IT Division and Directorno datano data0.11%
¥ 3.0m
Joji Suzuki
Independent Outside Director4.25yrsno data0.0070%
¥ 184.8k
Hideaki Mihara
Outside Auditor4.25yrsno data0.00054%
¥ 14.3k
Masashi Mizunaga
Independent Outside Director4.25yrsno datano data
Kazutaka Suzuki
Outside Corporate Auditor7.25yrsno data0.0021%
¥ 56.8k
Makoto Matsuo
4.25yrsno data0.0021%
¥ 56.8k

7.3yrs

Average Tenure

61yo

Average Age

Experienced Board: IUSD.F's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

AS ONE Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: AS ONE Corporation
  • Ticker: IUSD.F
  • Exchange: OTCPK
  • Founded: 1933
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: JP¥280.465b
  • Listing Market Cap: JP¥2.655b
  • Shares outstanding: 18.67m
  • Website: https://www.as-1.co.jp

Number of Employees


Location

  • AS ONE Corporation
  • 2-1-27, Edobori
  • Nishi-ku
  • Osaka
  • 550-8527
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IUSD.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 1995
7476TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYNov 1995

Biography

AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. It offers scientific instruments comp ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/26 05:31
End of Day Share Price2020/06/29 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.